Distinct stem/progenitor cells proliferate to regenerate the trachea,intrapulmonary airways and alveoli in COVID-19 patients  

作　　者：Yinshan Fang Helu Liu Huachao Huang Haiyan Li Anjali Saqi Li Qiang Jianwen Que 

机构地区：[1]Center for Human Development and Division of Digestive and Liver Disease,Department of Medicine,Columbia University Medical Center,New York 10032 NY,USA [2]Department of Pathology,Westchester Medical Center,Valhalla 10595 NY,USA [3]Department of Pathology&Cell Biology,Columbia University Medical Center,New York 10032 NY,USA

出　　处：《Cell Research》2020年第8期705-707,共3页细胞研究（英文版）

摘　　要：Dear Editor,The global pandemic COVID-19 caused by SARS-CoV-2 virus has infected over 6.5 million individuals and claimed over 350,000 lives worldwide within six months.The respiratory epithelial cells covering the airways and alveoli are the major targets of the virus.Moreover,damage to the epithelium can be exacerbated by mechanical ventilation.It is expected that many of the infected individuals that survived the acute phase will develop pulmonary diseases(e.g.fibrosis)if the epithelium fails to regenerate properly.

关 键 词：EPITHELIUM PROPERLY claimed 

分 类 号：R563.1[医药卫生—呼吸系统]